Clinical Trial Update: A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo- and active-controlled study of ONO-6950 in asthmatic patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ONO-6950

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Asthma | Phase 2 | Status: COMPLETED